Luciana Borio is a Brazilian-American infectious disease physician, public health expert, and venture capitalist. She is a Senior Fellow for Global Health at the Council on Foreign Relations, and a Venture Partner at Arch Venture Partners. From 2019 to 2021, Borio was a vice president at In-Q-Tel. She previously served as director for Medical and Biodefense Preparedness at the National Security Council, acting chief scientist of the U.S. Food and Drug Administration (FDA), assistant commissioner for counterterrorism policy of the FDA, and director of FDA's Office of Counterterrorism and Emerging Threats. She is known for her work advancing clinical trials, the development of medical countermeasures for health emergencies, and the responses to domestic and international public health emergencies.